Morgan Stanley Raises PT on Astera Labs (ALAB) to $200 From $155, Keeps an Overweight Rating

Astera Labs, Inc. (NASDAQ:ALAB) is one of the best hot large cap stocks to buy according to hedge funds. On August 29, Morgan Stanley analyst Joseph Moore raised the firm’s price target on Astera Labs, Inc. (NASDAQ:ALAB) to $200 from $155, keeping an Overweight rating on the shares.

Astera Labs (ALAB) Soars 19% As AI Boom Boosts Q2 Earnings Expectations

The analyst told investors that the rack scale AI business brought about a greenfield opportunity worth $17 billion “virtually overnight,” bringing opportunities for Astera Labs, Inc. (NASDAQ:ALAB), and other companies, including Broadcom, Nvidia, Marvell, and more.

Astera Labs, Inc. (NASDAQ:ALAB) is a global semiconductor company that provides hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. The company’s operations are divided into the following geographical segments: Taiwan, China, United States, and Other.

While we acknowledge the potential of ALAB to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ALAB and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.